These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25884646)

  • 41. Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat.
    Raposinho PD; Broqua P; Hayward A; Akinsanya K; Galyean R; Schteingart C; Junien J; Aubert ML
    Neuroendocrinology; 2000 Jan; 71(1):2-7. PubMed ID: 10644893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of BIBP3226 and BIBP3435 on cytosolic calcium in neuropeptide Y Y1 receptor-transfected Chinese hamster ovary cells and wild type CHO-K1 cells.
    Van Liefde ; Vanderheyden PM; De Backer JP; Ebinger G; Vauquelin G
    J Recept Signal Transduct Res; 2001 Feb; 21(1):11-23. PubMed ID: 11693170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
    Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
    Gehlert DR; Shaw JL
    Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Actions of neuropeptide Y on the rat adrenal cortex.
    Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
    Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity.
    Kameda M; Kobayashi K; Ito H; Miyazoe H; Tsujino T; Nakama C; Kawamoto H; Ando M; Ito S; Suzuki T; Kanno T; Tanaka T; Tahara Y; Tani T; Tanaka S; Tokita S; Sato N
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4325-9. PubMed ID: 19487123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
    Holliday ND; Lam CW; Tough IR; Cox HM
    Mol Pharmacol; 2005 Mar; 67(3):655-64. PubMed ID: 15576634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of neuropeptide Y receptors for the treatment of obesity.
    Sato N; Ogino Y; Mashiko S; Ando M
    Expert Opin Ther Pat; 2009 Oct; 19(10):1401-15. PubMed ID: 19743896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists.
    Zarrinmayeh H; Nunes AM; Ornstein PL; Zimmerman DM; Arnold MB; Schober DA; Gackenheimer SL; Bruns RF; Hipskind PA; Britton TC; Cantrell BE; Gehlert DR
    J Med Chem; 1998 Jul; 41(15):2709-19. PubMed ID: 9667962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
    Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto L; Emmons A; Holmes IP; Montanari D; Norris R; Walters DJ; Watson SP
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4022-5. PubMed ID: 19581086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
    Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
    Körner M; Reubi JC
    J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropeptide Y as a partial agonist of the Y1 receptor.
    Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
    Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular dynamics of NPY Y1 receptor activation.
    Sylte I; Andrianjara CR; Calvet A; Pascal Y; Dahl SG
    Bioorg Med Chem; 1999 Dec; 7(12):2737-48. PubMed ID: 10658578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells.
    Zhang P; Zheng J; Vorce RL; Hexum TD
    Regul Pept; 2000 Feb; 87(1-3):9-13. PubMed ID: 10710282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites.
    Du P; Salon JA; Tamm JA; Hou C; Cui W; Walker MW; Adham N; Dhanoa DS; Islam I; Vaysse PJ; Dowling B; Shifman Y; Boyle N; Rueger H; Schmidlin T; Yamaguchi Y; Branchek TA; Weinshank RL; Gluchowski C
    Protein Eng; 1997 Feb; 10(2):109-17. PubMed ID: 9089810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of a hydrophobic pocket of the human Y1 neuropeptide Y receptor in ligand binding.
    Sautel M; Martinez R; Munoz M; Peitsch MC; Beck-Sickinger AG; Walker P
    Mol Cell Endocrinol; 1995 Aug; 112(2):215-22. PubMed ID: 7489825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.